Vincenza Conteduca
Overview
Explore the profile of Vincenza Conteduca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
2872
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fiala O, Buti S, Fujita K, de Liano A, Fukuokaya W, Kimura T, et al.
Clin Exp Metastasis
. 2025 Feb;
42(2):18.
PMID: 39976819
Patients with metastatic urothelial carcinoma (mUC) are typically elderly and often have other comorbidities that require the use of concomitant medications. In our study we evaluated the association of concomitant...
2.
Garofoli M, Maiorano B, Bruno G, Giordano G, Falagario U, Necchi A, et al.
Eur Urol Oncol
. 2024 Dec;
PMID: 39627072
Background And Objective: Circulating tumor DNA (ctDNA) testing provides valuable prognostic and predictive information for guiding therapeutic choices and monitoring disease progression and drug resistance for urological tumors. Our review...
3.
Giunta E, Roviello G, Conteduca V, Verzoni E, Procopio G, De Giorgi U
Crit Rev Oncol Hematol
. 2024 Oct;
204:104534.
PMID: 39447667
The definition of "non-metastatic hormone-sensitive prostate cancer" (nmHSPC) can be applied to patients with prostate cancer (PC) who are androgen-deprivation therapy-naïve and without evidence of metastatic disease. This definition includes...
4.
Bruno G, Pietrafesa M, Crispo F, Piscazzi A, Maddalena F, Giordano G, et al.
J Mol Med (Berl)
. 2024 Aug;
102(10):1285-1296.
PMID: 39210159
Metabolic rewiring promotes cancer cell adaptation to a hostile microenvironment, representing a hallmark of cancer. This process involves mitochondrial function and is mechanistically linked to the balance between mitochondrial biogenesis...
5.
Perez-Navarro E, Conteduca V, Funes J, Dominguez J, Martin-Serrano M, Cremaschi P, et al.
Cancers (Basel)
. 2024 Jul;
16(14).
PMID: 39061175
The prognosis for patients with metastatic castration-resistant prostate cancer (mCRPC) varies, being influenced by blood-related factors such as transcriptional profiling and immune cell ratios. We aimed to address the contribution...
6.
Del Re M, Crucitta S, Brighi N, Kinspergher S, Mercinelli C, Rizzo M, et al.
Clin Genitourin Cancer
. 2024 Jul;
22(5):102147.
PMID: 39030142
Introduction: The administration of proton pump inhibitors (PPIs) is a common practice to reduce gastro-esophageal adverse events associated with drug treatments but may impair absorption and exposure to oncology drugs....
7.
Garofoli M, Maiorano B, Bruno G, Giordano G, Di Tullio P, Maselli F, et al.
Ther Adv Med Oncol
. 2024 Jun;
16:17588359241258443.
PMID: 38887656
Aberrations in the homologous recombination repair (HRR) pathway in prostate cancer (PCa) provide a unique opportunity to develop therapeutic strategies that take advantage of the reduced tumor ability to repair...
8.
Guida A, Mosillo C, Mammone G, Caserta C, Sirgiovanni G, Conteduca V, et al.
Cancer Treat Rev
. 2024 May;
128:102766.
PMID: 38763054
DNA-damage repair (DDR) pathways alterations, a growing area of interest in oncology, are detected in about 20% of patient with prostate cancer and are associated with improved sensitivity to poly(ADP...
9.
Buti S, Olivari A, Masini C, Bimbatti D, Sartori D, Ermacora P, et al.
Ther Adv Urol
. 2024 Apr;
16:17562872241244574.
PMID: 38638242
Background: The treatment of heavily pretreated patients with metastatic renal cell carcinoma (mRCC) represents an unmet medical need and is still challenging. Objectives: The primary objective was to assess the...
10.
Casadei C, Scarpi E, Conteduca V, Gurioli G, Cursano M, Brighi N, et al.
Eur Urol Open Sci
. 2024 Feb;
61:44-51.
PMID: 38384439
Background: The prevalence of pathogenic germline mutations in DNA damage repair (gDDR) genes in the Italian population is unknown. Objective: In this prospective multicenter cohort study, we evaluated the prevalence...